AMRIXAL 30

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

CYCLOBENZAPRINE HYDROCHLORIDE 30 MG

MAH:

PHARMASWISS ISRAEL LTD

ATC_code:

M03BX08

pharmaceutical_form:

CAPSULES EXTENDED RELEASE

administration_route:

PER OS

manufactured_by:

APTALIS PHARMATECH INC, USA

therapeutic_group:

CYCLOBENZAPRINE

therapeutic_indication:

Amrixal is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion.

authorization_date:

2011-08-01